Researchers evaluate artemisinin for COVID-19 management
4.8 (590) · $ 23.99 · In stock
Researchers assessed the effectiveness of artemisinin-based antimalarials in the management of COVID-19.
Research shows a relationship between increased SARS-CoV-2
Antiseptics News, Research
Cells, Free Full-Text
Safety concerns hamper study of hydroxychloroquine to prevent
Leon launches plant-based partnership with Heura - Industrial News
Researchers develop new method to synthesize antimalarial drug
Infinitea Artemisia
Extracts from artemisia annua plant found to be active against SARS-CoV-2 virus under laboratory conditions, artemisia annua
Pharmacological treatment of COVID-19: an update
UK Launches Clinical Trial to Evaluate Novel Treatments for COVID
Dr. Eduardo Patrick Beltran Monasterio on LinkedIn: The LGS Protocol: An Epigenetic Solution for Treating Autoimmune Diseases
Dihydroartemisinin News, Research
Antiseptics News, Research
Artemisinin News, Research
COVID-19 Lockdown Exit Analysis
